Stay updated with breaking news from Nasdaq Drrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five research firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target […]
DURECT Co. (NASDAQ:DRRX – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 927,500 shares, a decline of 10.0% from the March 31st total of 1,030,000 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is […]
Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […]
Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have received an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target […]
StockNews.com lowered shares of DURECT (NASDAQ:DRRX – Free Report) from a hold rating to a sell rating in a report released on Friday morning. Other equities research analysts have also issued research reports about the company. HC Wainwright lowered DURECT from a buy rating to a neutral rating in a research report on Tuesday, November […]